• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Siemens Healthcare’s ‘Healthineers’ re-branding is widely panned

Siemens Healthcare’s ‘Healthineers’ re-branding is widely panned

May 6, 2016 By Brad Perriello

Siemens HealthineersThe re-branding of German conglomerate Siemens‘s (NYSE:SI) healthcare business as “Siemens Healthineers” – and the mandatory concert it threw for 44,000 employees – have drawn widespread scorn across the globe.

The new name is intended to underline its pioneering spirit, Siemens said in a statement.

“Healthineers will continue to strengthen its leading portfolio across the medical imaging and laboratory diagnostics business while adding new offerings,” the company said.

The new offerings are slated to include managed services, consulting and digital services as well as further technologies in the growing market for therapeutic and molecular diagnostics, the company said.

A Youtube video of the concert, featuring Siemens executives and a troupe of orange- and blue-clad performers dancing to a theme song created to market the re-branding, prompted a storm of incredulous mockery on the Internet:

“This is an embarrassment. There’s nothing else I can say. I feel bad for everyone involved. And all the employees who were most likely forced to attend should have started a riot and razed the entire place to the ground.”

“Literally throwing money out a 20th story window is a better use of it than any spending on this garbage.”

“Because the name of the company alone isn’t embarrassing enough.”

“The cringe is strong with this one.”

Those sentiments were echoed on other sites around the Web.

At least 1 observer, however, thinks the criticism is over-done.

“Users of Siemens’ brain-scanners and plasma protein analyzers will care little about the brand name. They will mostly remain unmoved by the sight of people dancing in orange and blue bodysuits at the brand’s official launch. They are unlikely to hum along to the Healthineers theme song as they slide patients in and out of Siemens’ MRI machines. Staff will notice, but beyond being a bit embarrassed, they are unlikely to leave in droves. They may grow to like their new epithet,” Reuters Breakingviews columnist Olaf Storbeck wrote. “For investors, the clumsy rebranding is, at the margin, a good thing: it shows a spin-off of Siemens’ prime division may have become more likely. Healthcare in 2015 accounted for 17% of Siemens’ industrial revenue but 28% of its industrial operating profit. The division is meeting Siemens boss Joe Kaeser’s ambitious margin target of 15% to 19%.”

Earlier this week Siemens reported single-digit sales and earnings increases for its healthcare business during its fiscal 2nd quarter, on strong contributions from its diagnostic imaging business and currency hedges.

Siemens Healthcare’s profits were up 5.5% to $482.8  million (€555 million) on sales growth of 3.3% to $2.89 billion (€3.32 billion).

UPDATE Dec. 20, 2016: Although Siemens had the original video taken down, here’s a look at the dance routine that created all the fuss:

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: Siemens

More recent news

  • Massachusetts Life Sciences Center offers grants to lower medtech commercial risk
  • The 10 largest medical device companies
  • CSL to drop Terumo for Haemonetics in US plasma collection supply deal
  • How 5 medtech CEOs design for access
  • Butterfly Network to chase ultrasound brain-computer interfaces with newcomer Bridge Neurotech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy